U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Nucleic Acid
Created
by admin
on Wed Apr 02 15:42:46 GMT 2025
Edited
by admin
on Wed Apr 02 15:42:46 GMT 2025
Nucleic Acid Type mRNA VACCINE
Sequence Origin VIRAL
Sequence Type COMPLETE
Record UNII
JSV288Q5CV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RNA (recombinant 5?-[1,2-[(3?-O-methyl)m7G-(5??5?)-ppp-Am]]-capped all uridine?N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 spike glycoprotein secretory signal peptide plus codon-optimized pre-fusion spike glycoprote
Preferred Name English
Famtozinameran
INN  
Official Name English
BNT162b2 Omicron (BA.4/BA.5) mRNA
Common Name English
BNT162b2 Omicron (BA.4/BA.5)
Code English
Famtozinameran [WHO-DD]
Common Name English
famtozinameran [INN]
Common Name English
Code System Code Type Description
SMS_ID
300000046473
Created by admin on Wed Apr 02 15:42:46 GMT 2025 , Edited by admin on Wed Apr 02 15:42:46 GMT 2025
PRIMARY
NCI_THESAURUS
C190751
Created by admin on Wed Apr 02 15:42:46 GMT 2025 , Edited by admin on Wed Apr 02 15:42:46 GMT 2025
PRIMARY
INN
12809
Created by admin on Wed Apr 02 15:42:46 GMT 2025 , Edited by admin on Wed Apr 02 15:42:46 GMT 2025
PRIMARY
DAILYMED
JSV288Q5CV
Created by admin on Wed Apr 02 15:42:46 GMT 2025 , Edited by admin on Wed Apr 02 15:42:46 GMT 2025
PRIMARY
FDA UNII
JSV288Q5CV
Created by admin on Wed Apr 02 15:42:46 GMT 2025 , Edited by admin on Wed Apr 02 15:42:46 GMT 2025
PRIMARY
Sugar Site Range Site Count
D-Ribose (RNA) 1_1-1_4268 4268 / 4268
Linkage Site Range Site Count
Phosphate 1_2-1_4268 4267 / 4267
Related Record Type Details
EXPRESSED PROTEIN->VECTOR
TARGET ORGANISM->VACCINE ANTIGEN

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
NUCLEOSIDE_SUBSTITUTION U N1-METHYLPSEUDOURIDINE 09RAD4M6WF
NUCLEOTIDE SUBSTITUTION [1_1] 5'-TERMINUS Amount: m2-7,3’-OGppp(m1-2’-O)Ap mRNA CAP VNP8CZY34V